20.7 C
New York
Tuesday, August 16, 2022
HomeBusiness NewsStocks Taking Sector High: Pinnacle Entertainment Inc. (NYSE:PNK), Actavis plc (NYSE:ACT), Baxter...

Stocks Taking Sector High: Pinnacle Entertainment Inc. (NYSE:PNK), Actavis plc (NYSE:ACT), Baxter International Inc. (NYSE:BAX)

Date:

Related stories

Silicon Valley Stunned by the Fulminant Slashed Investments

I actually first read this as alkalizing meaning effecting...

The Next Wave of Superheroes Has Arrived with Astonishing Speed

I actually first read this as alkalizing meaning effecting...

Watch Awesome Kate Halle Go Full Wiming Pro in the Bahamas

I actually first read this as alkalizing meaning effecting...

The Weirdest Places Ashes Have Been Scattered in New Zeeland

I actually first read this as alkalizing meaning effecting...

The Car Insurance Catch that can Double Your Cover in Two Months

I actually first read this as alkalizing meaning effecting...
spot_imgspot_img

Pinnacle Entertainment Inc. (NYSE:PNK) [Trend Analysis] released that it has selected Charles Atwood to its Board, effective March 12, 2015. Commenting on Atwood, the firm reported that he is currently the Lead Trustee of the board of trustees for Equity Residential (EQR), a REIT listed on the New York Stock Exchange and member of the S&P 500. He is as well a member of the BODs of Gala Coral Group, a private -based gaming company, and ALST Casino Holdings, LLC, a private-based gaming and hospitality company. On the other consideration, Pinnacle Entertainment Inc. (NYSE:PNK) begun last trade with a price of $33.91 and throughout the trading session climbed at $34.47. The day-trade ended with a gain of 2.14% to closed at $34.39.

Actavis plc (NYSE:ACT) [Trend Analysis] released that the U.S. FDA has permitted that its supplemental new drug application for SAPHRIS as monotherapy for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients. SAPHRIS will be available for pediatric patients with bipolar I disorder in 2.5 mg, 5 mg and 10 mg black cherry flavor sublingual tablets in the second quarter of 2015. Shares of Actavis plc (NYSE:ACT) opened at $297.98 with 279.53 million outstanding shares and hit to its highest price of $299.50 during the day and finally closed at $298.95 by scoring 0.11%. In the whole session, it traded on volume of 2.66 Million shares, which turned higher than its average volume.

Baxter International Inc. (NYSE:BAX) [Trend Analysis] released that its optimistic results from its Phase III clinical trial evaluating the safety as well as efficacy of BAX 817, an investigational recombinant factor VIIa or rFVIIa treatment for people with hemophilia A or B who develop inhibitors. The potential, open-label, randomized, multicenter trial was to assess the safety and efficacy of BAX 817 in male patients aged 12 to 65 with hemophilia A or B, with inhibitors over a 6-month period using on-demand therapy. Baxter International Inc. (NYSE:BAX) stock hit highest price at $67.47, beginning with a price of $66.99 to the closed at 67.36 by an increase of 0.54% with a day range of $66.76-$67.47.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

spot_img